Showing results (31-40 of 255) with videos related to
Sort By:
Pageof 26
Clinical and Experimental Medicine|March 5, 2020
"Mixed connective tissue disease": a condition in search of an identityMarta R Alves, David A IsenbergExpert Opinion on Biological Therapy|November 20, 2020
The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?Ana Lorenzo-Vizcaya, David A IsenbergRheumatology (Oxford, England)|November 19, 2011
Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimenAmara N Ezeonyeji, David A IsenbergCurrent Opinion in Hematology|May 16, 2009
mAbs in nonlupus autoimmune rheumatic diseaseBryan R Whelan, David A IsenbergClinical and Experimental Rheumatology|September 21, 2013
Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathiesFrancisco Muñoz-Beamud, David A IsenbergTrends in Immunology|August 16, 2017
TRIM21 and the Function of Antibodies inside CellsDavid A Rhodes, David A IsenbergRheumatology (Oxford, England)|April 17, 2018
Recent developments in biologic therapies for the treatment of patients with systemic lupus erythematosusPedro L Carreira, David A IsenbergTherapeutic Advances in Musculoskeletal Disease|March 28, 2017
Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulnessSara Guerreiro Castro, David A IsenbergExpert Review of Clinical Immunology|May 19, 2010
Childhood- and adult-onset lupus: an update of similarities and differencesEva D Papadimitraki, David A IsenbergCurrent Opinion in Rheumatology|December 5, 2006
Syndromes and complications of interferon therapyFrances A Y Borg, David A IsenbergPageof 26